Get Pregnant With Your Own Eggs
One third of women who come to CHR looking for donor eggs end up conceiving with their own eggs.
Many women who have been diagnosed with diminished ovarian reserve (DOR) – whether as a result of premature ovarian aging or advanced age – are often refused treatment at fertility centers unless they are willing to use donor eggs. At CHR, we help women conceive with their own eggs even if other fertility clinics have said that receiving donor eggs is the only remaining option.
Women with DOR lack the ability to produce a good quantity of high-quality eggs. This ability declines naturally with age and prematurely with premature ovarian aging.
Our effective treatment plan for diminished ovarian reserve starts with a timely diagnosis. First, we will assess your FSH and AMH levels. Instead of using universal cut-off values for all patients – a practice employed by many infertility clinics – we will check these hormone values against where they should be at your age. Once we assess these values, we will discuss the most appropriate treatment options with you.
By no means will a diagnosis of DOR mean that your options to conceive are absolutely over. The condition is treatable, and with the right approach, many women go on to have safe and successful pregnancies.
One of our most successful approaches to treating DOR is the integrated treatment plan that our world-renowned fertility experts have developed through research and clinical experience over more than thirty years.
Our treatment approach incorporates three central elements:
- An individualized ovarian stimulation protocol (the process that yields eggs for fertilization) tailored to the patient’s ovarian reserve
- Pre-stimulation supplementation with DHEA, which improves the ovarian environment in which eggs mature
- Individualized management that focuses on addressing associated medical conditions (such as autoimmune disease) that may affect fertility
If you would like to learn more about diminished ovarian reserve, conceiving with your own eggs, or pregnancy over 40, please ask our doctors at the CHR via our contact form, or just call us for an appointment: (212) 994-4400.****
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over 17,800 babies into the world.Discover your treatment options
- A new clinical trial at CHR for women who need growth hormone: Rx SemorelinHuman growth hormone (HGH) has over the last decade returned to popularity in IVF cycles and is increasingly utilized at many
- An additional Ovarian Rejuvenation Trial with platelet-rich plasma (PRP)CHR recently announced and registered a third PRP trial. For those who do not recall our prior discussions of PRP
- How to individualize fertility treatments in women with low functional ovarian reserve (LFOR)We here continue the series on how to individualize fertility treatments in women with low functional ovarian reserved (LFOR), often also
- How to individualize fertility treatment for women with low functional ovarian reserve (LFOR)#1 in a series on DOR/LFOR With CHR, likely being an extreme example (median age 43 years), patient populations in